NCT01542944View on ClinicalTrials.gov

TevaGastrim for Stem Cell Mobilization Sibling Donors

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Interventions
DRUG

TevaGastrim

TevaGastrim 10 mg/kg SC will be administered in the evening for 4 days prior to apheresis.

Trial Locations (1)

52621

Chaim Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT01542944 - TevaGastrim for Stem Cell Mobilization Sibling Donors | Biotech Hunter | Biotech Hunter